Merck Introduces mRNA Vaccine to Slash Melanoma Risks
How the New mRNA Vaccine Targets Skin Cancer Pharmaceutical giants Merck and Moderna are shaking up oncology with a personalized mRNA vaccine that significantly lowers disease recurrence. Designed for patients fighting aggressive skin cancer, the experimental treatment pairs with standard immunotherapy to outsmart stubborn tumor cells. In recent Phase 3 clinical data, this combination reduced … Read more